Brief: Tetra Bio Pharma Submits Multiple Applications For Orphan Drug Designation For Cannabinoids To U.S. FDA
23/08/2018 13:16
Aug 23 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO PHARMA - SUBMISSION OF MULTIPLE APPLICATIONS FOR
ORPHAN DRUG DESIGNATION FOR CANNABINOIDS TO U.S. FOOD AND DRUG
ADMINISTRATION
Source text for Eikon: ID:nGNXc5XhvK
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding